Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System
- Status
- COMPLETED
- Phase
- PHASE2
A Study Of The Selective PKC-β Inhibitor MS- 553
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Copanlisib and Rituximab in Marginal Zone Lymphoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Activity and Safety of Front-line Venetoclax and Rituximab in Young and Fit Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab Combining Bortezomib Versus Rituximab in Management of ITP
- Status
- UNKNOWN
- Phase
- PHASE3
Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)
- Status
- COMPLETED
- Phase
- PHASE1
Atezolizumab, Rituximab, Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory DLBCL Not Suitable for High-dose Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Status
- RECRUITING
- Phase
- PHASE3
Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab
- Status
- COMPLETED
- Phase
- PHASE4
Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3